Celcuity Inc. (NASDAQ:CELC) Given Average Rating of “Buy” by Analysts

Celcuity Inc. (NASDAQ:CELC) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $29.17.

A number of equities research analysts have commented on CELC shares. Stifel Nicolaus raised their target price on Celcuity from $39.00 to $42.00 and gave the company a “buy” rating in a report on Monday, October 7th. HC Wainwright reiterated a “buy” rating and issued a $27.00 price objective on shares of Celcuity in a research note on Friday, November 15th. Needham & Company LLC restated a “buy” rating and set a $23.00 target price on shares of Celcuity in a research report on Friday, November 15th. Finally, Lifesci Capital began coverage on shares of Celcuity in a research report on Monday, August 26th. They set an “outperform” rating and a $27.00 price target for the company.

Hedge Funds Weigh In On Celcuity

Several hedge funds have recently added to or reduced their stakes in CELC. State Street Corp grew its position in shares of Celcuity by 152.2% in the third quarter. State Street Corp now owns 1,107,415 shares of the company’s stock valued at $16,512,000 after purchasing an additional 668,318 shares during the last quarter. Samlyn Capital LLC lifted its stake in Celcuity by 92.4% in the 2nd quarter. Samlyn Capital LLC now owns 1,326,953 shares of the company’s stock valued at $21,735,000 after buying an additional 637,190 shares in the last quarter. Braidwell LP grew its holdings in Celcuity by 71.2% during the 3rd quarter. Braidwell LP now owns 884,306 shares of the company’s stock valued at $13,185,000 after buying an additional 367,663 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in Celcuity by 226.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 221,671 shares of the company’s stock worth $3,305,000 after buying an additional 153,712 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Celcuity by 27.6% in the third quarter. Geode Capital Management LLC now owns 630,369 shares of the company’s stock worth $9,401,000 after acquiring an additional 136,518 shares during the last quarter. 63.33% of the stock is currently owned by hedge funds and other institutional investors.

Celcuity Stock Performance

Shares of CELC stock opened at $13.19 on Monday. The company has a current ratio of 10.35, a quick ratio of 10.36 and a debt-to-equity ratio of 0.65. Celcuity has a 12-month low of $11.51 and a 12-month high of $22.19. The company has a market cap of $489.74 million, a price-to-earnings ratio of -5.05 and a beta of 0.76. The stock has a 50 day simple moving average of $14.90 and a 200-day simple moving average of $15.87.

Celcuity Company Profile

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.